Cargando…

Protective role of N-acetylcysteine (NAC) on human sperm exposed to etoposide

BACKGROUND: Although recent progress in cancer treatment has increased patient survival and improved quality of life, reproductive side effects are still for concern. One way to decrease gonadal impairment is to use cytoprotectors. In testicular cancer, etoposide is generally used in combination wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Baetas, João, Rabaça, Ana, Gonçalves, Ana, Barros, Alberto, Sousa, Mário, Sá, Rosália
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6366041/
https://www.ncbi.nlm.nih.gov/pubmed/30774957
http://dx.doi.org/10.1186/s12610-018-0082-2
_version_ 1783393531025424384
author Baetas, João
Rabaça, Ana
Gonçalves, Ana
Barros, Alberto
Sousa, Mário
Sá, Rosália
author_facet Baetas, João
Rabaça, Ana
Gonçalves, Ana
Barros, Alberto
Sousa, Mário
Sá, Rosália
author_sort Baetas, João
collection PubMed
description BACKGROUND: Although recent progress in cancer treatment has increased patient survival and improved quality of life, reproductive side effects are still for concern. One way to decrease gonadal impairment is to use cytoprotectors. In testicular cancer, etoposide is generally used in combination with other agents, but there are no in-vitro studies of sperm exposure to etoposide and cytoprotectors, namely N-acetylcysteine (NAC). METHODS: Twenty semen samples were individually divided into five groups: control, incubation with NAC alone, incubation with etoposide alone, sequential exposure of NAC followed by etoposide (pre-treatment) and sequential exposure of etoposide followed by NAC (post-treatment). Sperm characteristics, chromatin condensation (aniline blue), DNA fragmentation (TUNEL), oxidative stress (OxyDNA labelling) and glutathione quantification were used to evaluate the capabilities of NAC as a prophylactic (pre-treatment) or ameliorator (post-treatment) agent over the effects caused in sperm during in-vitro exposure to etoposide. RESULTS: No deleterious effects were observed on sperm motility or sperm membrane integrity. Results revealed that prophylactic use of NAC (pre-treatment) increased rates of immature sperm chromatin as compared to ameliorator use of NAC (post-treatment), and increased rates of sperm DNA fragmentation in relation to controls. Pre and post-treatment with NAC increased oxidative levels in comparison to controls, but also increased levels of cellular antioxidant glutathione. CONCLUSIONS: The results indicate that NAC has the ability to counteract etoposide-induced toxicity rather than preventing the etoposide cytotoxic effects over sperm DNA, suggesting that the administration of NAC to cells formerly exposed to etoposide is preferable to its prophylactic use. As the results evidenced that NAC seems to be more efficient in attenuating sperm etoposide cytotoxic effects instead of being used as a chemoprophylactic agent, this reinforces the idea that there might be a new NAC mechanism over DNA.
format Online
Article
Text
id pubmed-6366041
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-63660412019-02-15 Protective role of N-acetylcysteine (NAC) on human sperm exposed to etoposide Baetas, João Rabaça, Ana Gonçalves, Ana Barros, Alberto Sousa, Mário Sá, Rosália Basic Clin Androl Research Article BACKGROUND: Although recent progress in cancer treatment has increased patient survival and improved quality of life, reproductive side effects are still for concern. One way to decrease gonadal impairment is to use cytoprotectors. In testicular cancer, etoposide is generally used in combination with other agents, but there are no in-vitro studies of sperm exposure to etoposide and cytoprotectors, namely N-acetylcysteine (NAC). METHODS: Twenty semen samples were individually divided into five groups: control, incubation with NAC alone, incubation with etoposide alone, sequential exposure of NAC followed by etoposide (pre-treatment) and sequential exposure of etoposide followed by NAC (post-treatment). Sperm characteristics, chromatin condensation (aniline blue), DNA fragmentation (TUNEL), oxidative stress (OxyDNA labelling) and glutathione quantification were used to evaluate the capabilities of NAC as a prophylactic (pre-treatment) or ameliorator (post-treatment) agent over the effects caused in sperm during in-vitro exposure to etoposide. RESULTS: No deleterious effects were observed on sperm motility or sperm membrane integrity. Results revealed that prophylactic use of NAC (pre-treatment) increased rates of immature sperm chromatin as compared to ameliorator use of NAC (post-treatment), and increased rates of sperm DNA fragmentation in relation to controls. Pre and post-treatment with NAC increased oxidative levels in comparison to controls, but also increased levels of cellular antioxidant glutathione. CONCLUSIONS: The results indicate that NAC has the ability to counteract etoposide-induced toxicity rather than preventing the etoposide cytotoxic effects over sperm DNA, suggesting that the administration of NAC to cells formerly exposed to etoposide is preferable to its prophylactic use. As the results evidenced that NAC seems to be more efficient in attenuating sperm etoposide cytotoxic effects instead of being used as a chemoprophylactic agent, this reinforces the idea that there might be a new NAC mechanism over DNA. BioMed Central 2019-02-07 /pmc/articles/PMC6366041/ /pubmed/30774957 http://dx.doi.org/10.1186/s12610-018-0082-2 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Baetas, João
Rabaça, Ana
Gonçalves, Ana
Barros, Alberto
Sousa, Mário
Sá, Rosália
Protective role of N-acetylcysteine (NAC) on human sperm exposed to etoposide
title Protective role of N-acetylcysteine (NAC) on human sperm exposed to etoposide
title_full Protective role of N-acetylcysteine (NAC) on human sperm exposed to etoposide
title_fullStr Protective role of N-acetylcysteine (NAC) on human sperm exposed to etoposide
title_full_unstemmed Protective role of N-acetylcysteine (NAC) on human sperm exposed to etoposide
title_short Protective role of N-acetylcysteine (NAC) on human sperm exposed to etoposide
title_sort protective role of n-acetylcysteine (nac) on human sperm exposed to etoposide
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6366041/
https://www.ncbi.nlm.nih.gov/pubmed/30774957
http://dx.doi.org/10.1186/s12610-018-0082-2
work_keys_str_mv AT baetasjoao protectiveroleofnacetylcysteinenaconhumanspermexposedtoetoposide
AT rabacaana protectiveroleofnacetylcysteinenaconhumanspermexposedtoetoposide
AT goncalvesana protectiveroleofnacetylcysteinenaconhumanspermexposedtoetoposide
AT barrosalberto protectiveroleofnacetylcysteinenaconhumanspermexposedtoetoposide
AT sousamario protectiveroleofnacetylcysteinenaconhumanspermexposedtoetoposide
AT sarosalia protectiveroleofnacetylcysteinenaconhumanspermexposedtoetoposide